Paraneoplastic hypercalcemia associated with uterine papillary serous carcinoma.
Hypercalcemia associated with endometrial carcinoma is rare. We report a patient with serous papillary endometrial carcinoma with paraneoplastic hypercalcemia due to parathyroid hormone-related peptide (PTHrP). To the best of our knowledge this is the first report of hypercalcemia due to PTHrP in this type of tumor.
Sachmechi
I
I
Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, New York, USA.
Kalra
J
J
Molho
L
L
Chawla
K
K
D000368:Aged; D018283:Cystadenocarcinoma, Papillary / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D016889:Endometrial Neoplasms / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications*; D007150:Immunohistochemistry; D015592:Immunoradiometric Assay; D010257:Paraneoplastic Syndromes / Q000150:complications* / Q000378:metabolism; D010281:Parathyroid Hormone / Q000097:blood; D044162:Parathyroid Hormone-Related Protein; D010388:Pelvis / Q000000981:diagnostic imaging; D011506:Proteins / Q000378:metabolism; D014057:Tomography, X-Ray Computed
C470121:PTHLH protein, human; D010281:Parathyroid Hormone; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins